https://www.marketscreener.com/quote/stock/QUINCE-THERAPEUTICS-INC-58071836/news/Quince-Therapeutics-to-Acquire-EryDel-SpA-and-its-Phase-3-Asset-Targeting-Ataxia-Telangiectasia-with-44399960/?utm_source=telegram&utm_medium=social&utm_campaign=share